The addition of lenvatinib/pembrolizumab to TACE showed a numerical improvement in PFS, but longer follow-up is necessary to ...
Improved education on drug toxicity management, especially within the first 90 days of treatment and regarding individualized ...
Findings from an exploratory 2a study showed improvements in patients with cancer cachexia with PH284 compared with placebo.
The FDA has approved sotorasib with panitumumab for adult patients with KRAS G12C-mutated metastatic colorectal cancer (mCRC) ...
Oncology nurses can educate patients on the benefits of subcutaneous administration, including reduced time in the infusion ...
The FDA approved acalabrutinib in combination with bendamustine and rituximab for adults with previously untreated mantle ...
Datopotamab deruxtecan-dlnk received approval from the FDA for previously treated unresectable or metastatic, HR-positive, HER2-negative breast cancer. The FDA granted approval to datopotamab ...
Novel Drug Combo Is Promising for PD-L1-Resistant Solid Cancers ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback